IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS
US Application 63/065,388
Filed on 2020-08-13
Filed on 2020-08-13
Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development
US Application 62/734,106
Filed on 2018-09-20
Filed on 2018-09-20
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2
US Application 63/008,949
Filed on 2020-04-13
Filed on 2020-04-13
Methods and Compositions For Promoting An Immune Response and For Combination Therapy
US Application 62/908,759
Filed on 2019-10-01
Filed on 2019-10-01
HIGH-THROUGHPUT GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES
US Application 63/068,458
Filed on 2020-08-21
Filed on 2020-08-21
METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY
US Application 62/992,715
Filed on 2020-03-20
Filed on 2020-03-20
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 62/981,856
Filed on 2020-02-26
Filed on 2020-02-26
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 62/976,655
Filed on 2020-02-14
Filed on 2020-02-14
Immunotherapy With An Immuninotoxin and Immunostimulator
US Application 62/927,753
Filed on 2019-10-30
Filed on 2019-10-30
SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES
US Application 62/988,783
Filed on 2020-03-12
Filed on 2020-03-12